Spruce Biosciences, Inc.
SPRB
$60.95
$0.891.48%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 48.91M | 10.67M | 16.39M | 25.62M | 38.75M |
| Total Receivables | 2.60M | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 353.00K | 932.00K | 1.87M | 2.90M | 3.18M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 253.00K | 2.92M | 2.70M | 2.06M | 2.28M |
| Total Current Assets | 52.11M | 14.52M | 20.95M | 30.58M | 44.21M |
|
|
|||||
| Total Current Assets | 52.11M | 14.52M | 20.95M | 30.58M | 44.21M |
| Net Property, Plant & Equipment | 666.00K | 735.00K | 803.00K | 869.00K | 934.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 243.00K | 62.00K | 64.00K | 204.00K | 69.00K |
| Total Assets | 53.02M | 15.31M | 21.82M | 31.65M | 45.21M |
|
|
|||||
| Total Accounts Payable | 943.00K | 1.39M | 807.00K | 1.88M | 1.30M |
| Total Accrued Expenses | 8.83M | 6.96M | 5.88M | 11.56M | 12.05M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 317.00K | 848.00K | 1.24M | 1.64M | 1.91M |
| Total Finance Division Other Current Liabilities | -- | 231.00K | 129.00K | 590.00K | -- |
| Total Other Current Liabilities | -- | 231.00K | 129.00K | 590.00K | -- |
| Total Current Liabilities | 10.09M | 9.43M | 8.06M | 15.67M | 15.25M |
|
|
|||||
| Total Current Liabilities | 10.09M | 9.43M | 8.06M | 15.67M | 15.25M |
| Long-Term Debt | -- | -- | -- | -- | 124.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 419.00K | 500.00K | 580.00K | 659.00K | 736.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 282.00K |
| Total Liabilities | 10.51M | 9.93M | 8.64M | 16.33M | 16.39M |
|
|
|||||
| Common Stock & APIC | 331.75M | 279.97M | 279.56M | 279.63M | 279.09M |
| Retained Earnings | -289.23M | -274.59M | -266.38M | -264.31M | -250.27M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 42.52M | 5.39M | 13.18M | 15.32M | 28.82M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 42.52M | 5.39M | 13.18M | 15.32M | 28.82M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 42.52M | 5.39M | 13.18M | 15.32M | 28.82M |
|
|
|||||